LabCompass

Mercy A. Okezue

Materials Science · Purdue University West Lafayette

Early career · publishing since 2019

Publications

28

Citations

96

Est. group size

~2

Recurring co-author estimate

Active years

8

Publishing since 2019

Research summary
AI-generated

Mercy A. Okezue's work focuses on pharmaceutical materials science, particularly the chemistry, crystal structure, and formulation of drugs such as bedaquiline (a tuberculosis medication) and levothyroxine. Her research includes creating different salt forms of drugs to improve solubility, determining crystal structures using X-ray diffraction, and designing nanoparticle-based drug delivery systems. She also contributes to work on laboratory quality management systems and accreditation in healthcare settings, particularly in African contexts.

Pharmaceutical crystal structure and salt formsDrug solubility and formulation optimizationNanoparticle drug delivery systemsX-ray diffraction and crystallographyLaboratory quality systems and accreditation

Publication output has been variable but generally active over the last decade, rising from no recorded output in 2017-2018 to a peak of 7 publications in 2024, with an average of about 3.4 publications per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.4/year recently
17182019: 2 publications192020: 6 publications202021: 3 publications212022: 5 publications222023: 2 publications232024: 7 publications7242025: 1 publication252026: 2 publications26
Recent publications
Publishes in
  • The Cambridge Structural Database×8
  • AAPS PharmSciTech×2
  • Pharmaceuticals×2
  • The Proceedings of the BIRS Community×2
  • BMC Health Services Research×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 20, 2026.

Claim or correct this profile